![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 50, 39125-39129, December 15, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Karolinska Institute, Division of Clinical Virology,
Huddinge University Hospital, S-141 86 Stockholm, Sweden
Nucleoside kinases from several species are
investigated as "suicide genes" for treatment of malignant tumors
by combined gene/chemotherapy. We have recently cloned a multisubstrate
deoxyribonucleoside kinase of Drosophila melanogaster
(Dm-dNK), and we have shown that the enzyme phosphorylates
cytotoxic pyrimidine and purine nucleoside analogs. The broad substrate
specificity of the enzyme, as well as its very high catalytic rate,
makes it a unique member of the nucleoside kinase enzyme family. In the
present study, we evaluated Dm-dNK as a suicide gene by
constructing a replication-deficient retroviral vector that expresses
the enzyme. The human pancreatic adenocarcinoma cell line MIA PaCa-2
and a thymidine kinase-deficient osteosarcoma cell line were transduced
with the recombinant virus. We showed that Dm-dNK can be
expressed in human cells, that the enzyme retained its enzymatic
activity, and that it is localized in the cell nuclei due to a nuclear
localization signal in its C-terminal region. The cells expressing
Dm-dNK exhibited increased sensitivity to several cytotoxic
nucleoside analogs, such as
1-
Retroviral Transduction of Cancer Cell Lines with the Gene
Encoding Drosophila melanogaster Multisubstrate
Deoxyribonucleoside Kinase*
-D-arabinofuranosylcytosine, 1-
-D-arabinofuranosylthymine,
(E)-5-(2-bromovinyl)-2'-deoxyuridine, 2-chloro-2'-deoxyadenosine, and 2',2'-difluorodeoxycytidine. These findings suggest that Dm-dNK may be used as a suicide gene
in combined gene/chemotherapy of cancer.
*
This work was supported by grants from the Swedish Medical
Research Council, the Swedish Cancer Foundation, the Swedish Foundation of Strategic Research, and the European Commission.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 46-8-58587932;
Fax 46-8-58587933; E-mail: anna.karlsson@mbb.ki.se.
This article has been cited by other articles:
![]() |
N. Solaroli, X. Zheng, M. Johansson, J. Balzarini, and A. Karlsson Mitochondrial Expression of the Drosophila melanogaster Multisubstrate Deoxyribonucleoside Kinase Mol. Pharmacol., December 1, 2007; 72(6): 1593 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zheng, M. Lundberg, A. Karlsson, and M. Johansson Lipid-mediated Protein Delivery of Suicide Nucleoside Kinases Cancer Res., October 15, 2003; 63(20): 6909 - 6913. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Knecht, G. E. Petersen, M. P. B. Sandrini, L. Sondergaard, B. Munch-Petersen, and J. Piskur Mosquito has a single multisubstrate deoxyribonucleoside kinase characterized by unique substrate specificity Nucleic Acids Res., March 15, 2003; 31(6): 1665 - 1672. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zheng, M. Johansson, and A. Karlsson Bystander Effects of Cancer Cell Lines Transduced with the Multisubstrate Deoxyribonucleoside Kinase of Drosophila melanogaster and Synergistic Enhancement by Hydroxyurea Mol. Pharmacol., August 1, 2001; 60(2): 262 - 266. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |